Navigation Links
Unilife Corporation Announces Financial Results For Fiscal Year 2013 First Quarter
Date:11/8/2012

YORK, Pa., Nov. 8, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced financial results for the quarter ended September 30, 2012, (the first quarter of Fiscal Year 2013).

Recent Highlights:

  • The continued expansion of the Unilife proprietary portfolio of innovative, differentiated device technologies with the addition of the LISA Reusable Auto-Injector, the Unilife Depot-Ject™ platform for implanting a drug depot and the Unilife Ocu-Ject™ platform for the injection of microliter sized doses.
  • The scheduled expansion of the commercial development team with several additional key hires that strengthen the position of Unilife to serve the unmet and emerging needs of a growing network of new and prospective pharmaceutical and biotechnology customers.
  • Mr. Alan Shortall, CEO of Unilife, said, "All fundamental areas of the Unilife business remain fully on track. Our commercial pipeline continues to strengthen in both size and scope. Discussions are advancing favorably with a significant number of pharmaceutical customers, many of whom are targeting at least one of our devices for use with several of their injectable therapies. The recent expansion of our commercial development team and strong exhibition at the PDA Universe of Prefilled Syringes Conference in Las Vegas should help to underline the favorable market perception Unilife continues to generate across the pharmaceutical market for injectable drug delivery systems.

    "With many negotiations regarding commercial supply contracts and clinical development agreements now at an advanced status, we look forward to generating attractive, incremental and long-term revenue streams. I expect shareholders should have reason to be pleased with our flow of agreements throughout Fiscal Year 2013 and beyond," Mr. Shortall concluded. '/>"/>

    SOURCE Unilife Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
    2. Unilife Granted Key U.S. Patent for Unifill Prefilled Syringe
    3. Unilife Corporation to Announce Financial Results for Fiscal 2012 Fourth Quarter and Year End on Monday, July 30, 2012
    4. Unilife Corporation Announces Financial Results For Fiscal Year 2012 Fourth Quarter
    5. Griffin Securities Analyst Interviews Unilife Corp. CEO in a Two-Part Video Series
    6. Unilife Corporation To Announce Financial Results For Fiscal 2013 First Quarter On Tuesday, October 30, 2012
    7. Second Part of the Griffin Securities Analyst Interview with Unilife Corp. CEO is Now Available
    8. Unilife Corporation Reschedules Release Of Quarterly Results And Earnings Call Due To Severe Weather In Northeastern U.S.
    9. Unilifes Bolus Injector Platform Targeted by Global Pharmaceutical Company for Use in Multi-Drug Program
    10. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
    11. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/4/2015)... 4, 2015  Eli Lilly and Company (NYSE: ... Diego (UCSD) of its intent to end its contract ... Treatment in Asymptomatic Alzheimer,s disease (A4) study. The A4 ... the preclinical stage of Alzheimer,s disease in older individuals ... a PET scan, but do not show symptoms of ...
    (Date:8/4/2015)... 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) ... Sangamo,s executive vice president, research and development, will provide ... ® development programs and an overview of the ... 11, 2015, at the 2015 Wedbush Pacgrow Healthcare Conference. ... York, NY . The presentation will ...
    (Date:8/4/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage ... treatment of autoimmune diseases, asthma and allergic diseases, ... second quarter ended June 30, 2015 and provided a ... eight XmAb® antibody candidates are in clinical testing, ... momentum of this pipeline of antibodies is a ...
    Breaking Medicine Technology:Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2Xencor Reports Second Quarter 2015 Financial and Operating Results 2Xencor Reports Second Quarter 2015 Financial and Operating Results 3Xencor Reports Second Quarter 2015 Financial and Operating Results 4Xencor Reports Second Quarter 2015 Financial and Operating Results 5Xencor Reports Second Quarter 2015 Financial and Operating Results 6Xencor Reports Second Quarter 2015 Financial and Operating Results 7Xencor Reports Second Quarter 2015 Financial and Operating Results 8Xencor Reports Second Quarter 2015 Financial and Operating Results 9
    (Date:8/4/2015)... ... August 04, 2015 , ... Angelina Jolie is in it at age ... every year. Dr. Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” ... scary unknown out of menopause. , Myth #1: Menopause only affects old ladies. ...
    (Date:8/4/2015)... ... , ... School is almost back in session. Parents and children are enjoying ... scramble. Dublin, OH family dentist , Dr. Cheung (of BrightSmile Dental) reminds parents ... In fact, the dentist recently updated the practice’s surgical suite to prepare for nervous ...
    (Date:8/4/2015)... ... 2015 , ... Many men are confused about the safety of testosterone replacement ... as a voice of authority for men seeking accurate information about testosterone. , ... and expertise in the safe and effective treatment of low testosterone. In recent years, ...
    (Date:8/4/2015)... ... August 04, 2015 , ... Buckeye ... entering kindergarten. All required immunizations are covered for members under the Healthchek program ... who aren’t caught up with their immunizations may not be allowed to attend ...
    (Date:8/4/2015)... ... August 04, 2015 , ... ... announced that Bruce McCalley joins its executive leadership team as Senior Vice President ... success at technology companies and expanding global markets with a special emphasis on ...
    Breaking Medicine News(10 mins):Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3
    ... specialist makes a difference, study finds , WEDNESDAY, Aug. 22 ... to see the doctor who diagnoses their melanoma, the more ... -- skin cancer at the time of diagnosis, a new ... poorer patients getting diagnosed with thicker melanomas, the researchers said. ...
    ... the brain, study suggests , , WEDNESDAY, Aug. 22 (HealthDay ... frightening, traumatic memories go so deep and linger so ... rats shows that a powerful neurochemical called norepinephrine is ... but it also "imprints" an emotional fear tagged to ...
    ... weak or unsubstantiated, review finds , TUESDAY, Aug. 21 (HealthDay ... disease often lack proper documentation or validation, experts report in ... American Medical Association . , A team of researchers in ... They found that 286 (66.2 percent) of these claims were ...
    ... Fried, baked food compound poses no threat, major study finds ... be little or no link between breast cancer and acrylamide, ... to the largest epidemiological study on the subject conducted to ... acrylamide in the diet does not appear to be an ...
    ... in Taiwan has shown that an 800-year-old formula, Four-Agents ... pain after three cycles of treatment; however, a beneficial ... dosage regimen and treatment length used in this study ... published in the August 15 issue of the online, ...
    ... A computer bug infected Web gamers, with ominous results, ... Online role-playing games could provide insight into how infectious ... the real world, American researchers report. , A programming ... ("corrupted blood") among virtual characters in the popular online ...
    Cached Medicine News:Health News:Melanoma Diagnosis Often Delayed for Rural Poor 2Health News:Study Probes Roots of Fearful Memories 2Health News:Gene Studies of Male-Female Differences Often Flawed 2Health News:Acrylamide Won't Raise Breast Cancer Risk 2Health News:Acrylamide Won't Raise Breast Cancer Risk 3Health News:Acrylamide Won't Raise Breast Cancer Risk 4Health News:Is 4 agents decoction (Si Wu Tang) efficacious in treating primary dysmenorrhea? 2Health News:Online 'Epidemic' Gives Clues to Bird Flu Spread 2
    ... specialty Eraser instruments have been designed ... the right tool for situations requiring ... series of 25 gauge intraocular, bipolar, ... treatment of target tissues for fine-tip ...
    Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
    Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
    ... explanation of foldable intraocular lenses. The instrument ... placed under the implant and divides the ... helps support both halves of the lens ... in the anterior chamber is avoided. The ...
    Medicine Products: